AI-Derived Heart Age Linked to Cardiovascular and Dementia-Related Mortality
Posted on 16 Nov 2026
Cardiovascular disease is increasingly associated with dementia-related mortality and other forms of age-related decline. Identifying people with greater long-term vulnerability before severe outcomes occur remains an important clinical challenge.
Because echocardiography is widely used to assess cardiac structure and function in routine care, it may offer additional prognostic information beyond standard interpretation. A new study now shows that artificial intelligence analysis of heart ultrasound images may help identify patients at increased long-term risk of cardiovascular or dementia-related death.
The analysis used a previously developed artificial intelligence age model applied to echocardiography clips of the heart. Researchers at Mayo Clinic in Rochester evaluated the model in a community-based cohort by comparing each participant’s AI-predicted biological heart age with their chronological age. The difference between the two was defined as the echocardiographic cardiac age gap.
The retrospective study included 568 adults aged 50 years or older who underwent echocardiography between 2002 and 2004. Investigators generated an average AI-predicted heart age for each participant from the ultrasound clips and then examined its association with cardiovascular- and dementia-related mortality over a 20-year follow-up period.
A larger cardiac age gap was associated with worse long-term outcomes. Each five-year increase in the echocardiographic cardiac age gap was linked to a 61% increase in 20-year cardiovascular- or dementia-related mortality after adjustment for age and sex. The association remained significant after further adjustment for body mass index and left ventricular ejection fraction, with each five-year increase associated with a 46% higher risk of mortality.
The findings were presented at the ESC Digital & AI Summit 2026. Cardiovascular- and dementia-related mortality were grouped together for practical reasons, and the investigators noted that separate AI age analyses could help further clarify relationships between cardiovascular and neurodegenerative disease. They also emphasized the need for larger prospective evaluations in independent cohorts.
“Results from a community-based cohort indicate that AI-derived cardiac aging signatures may serve as a marker to identify people with long-term vulnerability. These types of analyses may also be useful to study if lifestyle or medical interventions can reduce the cardiac age gap,” said Dr. Jeffrey G. Malins from Mayo Clinic in Rochester, U.S.
“Wider prospective evaluations of AI-derived cardiac aging signatures in larger, independent cohorts are now warranted,” added Dr. Malins.
Related Links
Mayo Clinic
European Society of Cardiology